This inventor holds 2 USPTO granted patents. Top assignees: Tonen Corporation, International Reagent Corporation, Tokyo Metropolitan Institute of Medical Science. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (1998)
- Itabashi-ku, JP (1999)
Company Filing History:
2 out of 141 
1 out of 1 
1 out of 56 Years Active: 1998-1999
Title: Tomiko Kashiwakuma: Innovator in Hepatitis Research
Introduction
Tomiko Kashiwakuma is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of hepatitis. With a total of 2 patents, her work has been instrumental in advancing immunological research.
Latest Patents
Kashiwakuma's latest patents include an immunoassay for non-A, non-B hepatitis virus-related antigens. This invention focuses on a monoclonal antibody that specifically binds to an antigenic determinant site on the core structural protein of the Non-A, Non-B hepatitis virus (NANBV). The patent also covers a hybridoma cell line capable of producing this monoclonal antibody, a process for its preparation, and a test kit for use in the immunoassay. The preferred monoclonal antibodies identified in her work are 5E3, 5F11, 515S, or 1080S. These antibodies can specifically recognize the NANBV core structural protein in sera from patients, making them valuable for the definitive diagnosis of Non-A, Non-B hepatitis.
Another significant patent involves antigenic peptides for growing hepatitis C virus. This invention relates to NS4-related antigenic peptides that react specifically with antibodies directed against Group I and Group II of hepatitis C virus (HCV). The patent includes a kit for identifying HCV Groups I or II, which comprises these peptides in separate sections. The peptides can be used to detect HCV Groups I or II specifically, as well as to identify patients with mixed infections, allowing for early and effective interferon treatment for HCV Group II-infected patients.
Career Highlights
Throughout her career, Tomiko Kashiwakuma has worked with notable organizations such as Tonen Corporation and the Tokyo Metropolitan Institute of Medical Science. Her experience in these institutions has contributed to her expertise in medical research and innovation.
Collaborations
Kashiwakuma has collaborated with esteemed colleagues, including Akira Hasegawa and Shintaro Yagi. These partnerships have further enhanced her research capabilities and have led to significant advancements in her field.
Conclusion
Tomiko Kashiwakuma's contributions to hepatitis research through her innovative patents have made a lasting impact on medical science. Her work continues to
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile